Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas. - Wikidata - wikimedia - TriplyDB

Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas.

Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas.

http://www.wikidata.org/entity/Q35011389

about

Differential expression of miRNAs in colorectal cancer: comparison of paired tumor tissue and adjacent normal mucosa using high-throughput sequencing Clinical outcome prediction by microRNAs in human cancer: a systematic review Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer Metabolism Participation of WNT and β-Catenin in Physiological and Pathological Endometrial Changes: Association with Angiogenesis Regulation of genes in the arachidonic acid metabolic pathway by RNA processing and RNA-mediated mechanisms MicroRNA-21 and the clinical outcomes of various carcinomas: a systematic review and meta-analysis miR-200c Regulation of Metastases in Ovarian Cancer: Potential Role in Epithelial and Mesenchymal Transition Downregulation of miR-101 in gastric cancer correlates with cyclooxygenase-2 overexpression and tumor growth Tumor-specific silencing of COPZ2 gene encoding coatomer protein complex subunit ζ 2 renders tumor cells dependent on its paralogous gene COPZ1 Identification of differentially expressed microRNAs in metastatic melanoma using next-generation sequencing technology Integration of mRNA expression profile, copy number alterations, and microRNA expression levels in breast cancer to improve grade definition.Down-regulated microRNA-101 in bladder transitional cell carcinoma is associated with poor prognosis miR-205 inhibits cell growth by targeting AKT-mTOR signaling in progesterone-resistant endometrial cancer Ishikawa cells.microRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer.Hsa-microRNA-101 suppresses migration and invasion by targeting Rac1 in thyroid cancer cells.The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells Prognostic significance of miR-205 in endometrial cancer.Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosis.MicroRNAs 125a and 455 repress lipoprotein-supported steroidogenesis by targeting scavenger receptor class B type I in steroidogenic cells.Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients MicroRNA profiling of salivary adenoid cystic carcinoma: association of miR-17-92 upregulation with poor outcome.MicroRNA-196a is a putative diagnostic biomarker and therapeutic target for laryngeal cancer.MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival DIANA-microT Web server upgrade supports Fly and Worm miRNA target prediction and bibliographic miRNA to disease association.Minireview: The roles of small RNA pathways in reproductive medicine Global epigenetic regulation of microRNAs in multiple myeloma.Therapeutic advances in women's cancers MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype.miR-200a/miR-141 and miR-205 upregulation might be associated with hormone receptor status and prognosis in endometrial carcinomas.Enforced expression of miR-101 inhibits prostate cancer cell growth by modulating the COX-2 pathway in vivo.MicroRNA screening identifies circulating microRNAs as potential biomarkers for osteosarcoma.Down-regulation of microRNA152 is associated with the diagnosis and prognosis of patients with osteosarcoma MicroRNA and endometrial cancer: Roles of small RNAs in human tumors and clinical applications (Review).In vitro and in vivo activity of miR-92a-Locked Nucleic Acid (LNA)-Inhibitor against endometrial cancer.Mapping the regulatory sequences controlling 93 breast cancer-associated miRNA genes leads to the identification of two functional promoters of the Hsa-mir-200b cluster, methylation of which is associated with metastasis or hormone receptor status i Altered expression of microRNA-451 in eutopic endometrium of baboons (Papio anubis) with endometriosis.microRNA expression profiling of endometrial endometrioid adenocarcinomas and serous adenocarcinomas reveals profiles containing shared, unique and differentiating groups of microRNAs Identification of Differentially Expressed miRNAs in Appendiceal Mucinous Cystadenocarcinoma from Mucinous Cystadenoma.

P2860

Q21134708-73F51C10-C3F8-458B-933A-6B4C391BA46D Q24289183-F4D7ECB4-2916-414B-83A8-6BAC1D30F52D Q26774456-A0CE3AE9-71F4-4DB9-AD50-CC433387B963 Q26787269-90A0D892-283A-4E59-8513-EE436EF7DC0F Q26849624-13EE4702-BE2C-45C3-A179-C910FA6ED817 Q26851333-2AC55DF3-5C08-4D53-9B6B-9EF18FA7B3C4 Q28071987-76C36934-D083-4A1D-B0E5-0C4641F59B8F Q28275778-30EB3A86-D536-4716-8CCD-3E3D34841B50 Q30502952-0FA646AA-E68E-49B8-A27F-FD4CB59ED13E Q33608762-FDE7AB94-6B32-41A3-83EF-4E4F09715A58 Q33670486-CEE6D94C-1979-4503-A9BD-88941B88F952 Q33686261-3C6FF211-F3DC-45E7-83C8-F2C6C0CFF337 Q33709560-DAED1D6D-47D1-4876-868F-C5A87E1FC7CB Q33784290-7944E2BA-A5EB-41CA-B8F6-7F57E59C71D7 Q34091442-49B3B1CB-93E4-43A9-A82E-2CAE7DD96405 Q34141872-0EBAACF1-D6F8-4E86-9FF4-4BDB13B8B302 Q34163386-B8920DF1-4A38-49C2-89A4-57615A5BAD7F Q34227586-17BE051D-767D-4F3F-87A3-A02CAEF31805 Q34238901-9604F7A3-4083-4685-A379-B908491DE243 Q34279691-8E178103-5FF6-4BB8-B51C-4FD14D1111F8 Q34304540-DBC7DE30-A9A8-4E5B-AF5C-1E2E6682FA89 Q34654554-70A1504C-E267-482D-A56D-1EAFAA9D35E2 Q34794257-430548CC-1C98-4777-BBB2-B84D2A6CFB3E Q34964080-9D4C2702-84C8-4418-BBF2-B5146D5D323B Q35061526-9E4526FF-9F52-4BA6-8974-3F9F232C4912 Q35075558-9A35100E-B9AC-4252-AE49-2BDE0A170016 Q35135678-299CD2EC-C9D4-45A0-B01E-9C63C8AFBDB3 Q35350129-FF0F8352-26A5-454D-A947-388AB8FA44A3 Q35418973-248E162F-A5A6-415C-BB84-FACCB01CF8A5 Q35553338-AD8BFD8C-F7EC-4A4C-8E0C-903C5663B2B0 Q35632200-00DCAD21-1520-4E29-B45A-96B0CB81FD7B Q35834571-D963FB1A-D351-4F72-A75B-28A959E0E064 Q35943345-6F7B1B5B-6BFE-4FAD-94AD-FD4F19524C52 Q36095261-6802F3EF-65A8-4403-AC23-A68395394DB3 Q36142558-9E7C8375-1E5E-4A66-973F-0B005F21D0E7 Q36174701-444A5998-1AA4-4AD1-AA5F-DEAD2C53F24D Q36250545-3B383AA2-6444-4888-B510-15989248B469 Q36276318-CAC5680B-9AD2-4E93-A38D-250FDF4B95BF Q36456399-A28A882F-47B3-4C05-B677-0C1908B35C33 Q36483432-DCB499A7-7D55-4331-A238-A843531251FD

P2860

Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas.

http://www.wikidata.org/entity/Q35011389

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Changes in microRNA expression ...... etrial serous adenocarcinomas.

@ast

Changes in microRNA expression ...... etrial serous adenocarcinomas.

@en

type

label

Changes in microRNA expression ...... etrial serous adenocarcinomas.

@ast

Changes in microRNA expression ...... etrial serous adenocarcinomas.

@en

prefLabel

Changes in microRNA expression ...... etrial serous adenocarcinomas.

@ast

Changes in microRNA expression ...... etrial serous adenocarcinomas.

@en

P1433

Q35011389-03ACE590-ABFF-4030-A123-84D74CD53E97

P1476

Q35011389-1BED7B63-35E9-4D1F-942F-DD8C6D779A3A

P2093

Q35011389-54419F15-1E8C-427F-9B6F-134F7DB13D8D

Q35011389-64A4F9EC-C4D9-436D-9F1F-BE007B3E3E74

Q35011389-80FAC555-172A-4B35-A1E1-0F52181E8EF2

Q35011389-A8C2E943-B5F0-4CCB-830B-0BCDA6486BA8

Q35011389-DB1F739D-9762-4D7B-B28D-C2D8A0083BE6

Q35011389-E0CAAE95-D3C7-4DC3-AEC5-4E7F18DFD39B

Q35011389-E0FE9E32-3306-45D7-B975-37F3D213D1F6

P304

Q35011389-053D85B9-6936-4A7B-9ADB-556F89AE5EE6

P31

Q35011389-38E02961-0A57-40C4-B062-F66001DFD911

P356

Q35011389-1E42BCDD-9C0C-4BE2-9746-3C4FF586C546

P433

Q35011389-9A75AEE0-6B2E-48D6-9181-8F7755C60BBF

P478

Q35011389-4C76ADBE-F6E6-4F5E-B054-33567B99C2E7

P50

Q35011389-75E84F61-28B8-4F10-9D2D-BFC72FD993E6

P577

Q35011389-234199DB-11F4-408D-B6CF-377606DC2AFC

P5875

Q35011389-263229B1-602B-4AE2-98F1-53F7372D43C6

P698

Q35011389-626309EF-7549-48CF-851A-8C44C7CD7527

P921

Q35011389-8A858A4D-E394-4198-B0B2-614ACD1CD5A9

Q35011389-F64ADBD0-5BEA-4A21-B351-0C06A4B46326

P356

J.1349-7006.2009.01385.X

P1433

P1476

Changes in microRNA expression ...... metrial serous adenocarcinomas

@en

P2093

Eri Hiroki

http://www.w3.org/2001/XMLSchema#string

Fumihiko Suzuki

http://www.w3.org/2001/XMLSchema#string

Hironobu Sasano

http://www.w3.org/2001/XMLSchema#string

Jun-Ichi Akahira

http://www.w3.org/2001/XMLSchema#string

Kiyoshi Ito

http://www.w3.org/2001/XMLSchema#string

Nobuo Yaegashi

http://www.w3.org/2001/XMLSchema#string

Takashi Suzuki

http://www.w3.org/2001/XMLSchema#string

P304

241-249

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1349-7006.2009.01385.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-10-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38069226

http://www.w3.org/2001/XMLSchema#string

P698

19891660

http://www.w3.org/2001/XMLSchema#string

P921

microRNA expression